Open-label follow-up study to investigate the seropersistence of TBE antibodies and the booster response to a tick-borne encephalitis vaccine in children and adolescents aged 3 - 18 years.

Registry ID

EUCTR2005-000767-26

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

Baxter AG

Start date

2005-05-09

Completion date

2008-07-25

Last update

2026-08-16

Conditions

• Tick-borne encephalitis

Summary

Seropositivity rate measured by ELISA and/or NT according to Adner et al., 2001 at each available time point after the third vaccination in study 209 and separately at each available time point after the booster vaccination in this study

Locations

• , , Austria
• , , Germany

View on source registry